Amyotrophic lateral sclerosis transcriptomics reveals immunological effects of low-dose interleukin-2

Ilaria Giovannelli(University of Sheffield), Janine Kirby(University of Sheffield), Christophe Masseguin(Centre Hospitalier Universitaire de Nîmes), Nadhim Bayatti(University of Sheffield), Carey Suehs(Université de Montpellier), Ammar Al‐Chalabi(King's College London), Marius Mickunas(King's College London), Cecília Garlanda(Humanitas University), Dennis Wang(Yale University), P. Nigel Leigh(University of Leeds), Ulf Andréasson(Sahlgrenska University Hospital), Timothy Tree(King's College London), John De Vos(Inserm), Andrea Malaspina(University College London), A.G. Brown(University of Sheffield), G. Bensimon(Université de Montpellier), Paul R. Heath(University of Sheffield), Raúl Juntas‐Morales(Université de Montpellier), Henrik Zetterberg(University of Wisconsin–Madison), Pamela J. Shaw(University of Sheffield), William Camu(Hôpital Gui de Chauliac), Christine Payan(Sorbonne Université), Jean‐Luc Veyrune(Université de Montpellier), Safa Saker(Genethon (France)), Nicolas Pageot(Université de Montpellier), Massimo Locati(Humanitas University)
Brain Communications
January 1, 2021
Cited by 28


Related Papers